Clinical Trials Browser

Uveal Melanoma × CTLA-4 Antigen × CNS × Clear all

NCT05341349 2026-04-23

Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-200M for the Treatment of Melanoma Brain Metastases

Phase 1 Terminated

CNSDermatologic

Uveal Melanoma, Brain Neoplasms, Melanoma